Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00295087 · ClinicalTrials.gov registry record

X-Chromosome Inactivation Status and Premature Ovarian Failure

A clinical trial of Premature Ovarian Failure, sponsored by University of Pittsburgh.

Completed
Registry status
13
Enrollment target
1
Study location

NCT00295087: Completed study of Premature Ovarian Failure, sponsored by University of Pittsburgh.

NCT00295087 is a study of Premature Ovarian Failure that has completed, run by University of Pittsburgh. The registered enrollment target is 13 participants, below the 86-participant average among 3 other Premature Ovarian Failure trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00295087, a study of Premature Ovarian Failure, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
13 participants
Enrollment target
1
Study location

Study Summary

Women who are affected with premature ovarian failure will exhibit skewed X-chromosome inactivation patterns compared to women with normal menstrual function (as defined by being pregnant), indicating a possible X-chromosome defect.

Conditions Studied

Study Locations (1)

Pennsylvania

  • Magee-Womens Hospital - Pittsburgh

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2005-11
Est. Completion 2009-10
University of Pittsburgh

1,238 total trials

What the finished NCT00295087 record still lists

NCT00295087 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 86-participant average among 3 other Premature Ovarian Failure trials with a reported enrollment target (85% lower).

The record links to 1 condition, with Premature Ovarian Failure appearing as the primary indexed condition, and to 0 interventions.

NCT00295087 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00295087 about?

NCT00295087 is a clinical study titled "X-Chromosome Inactivation Status and Premature Ovarian Failure". Women who are affected with premature ovarian failure will exhibit skewed X-chromosome inactivation patterns compared to women with normal menstrual function (as defined by being pregnant), indicating a possible X-chromosome defect.

What is the current status of trial NCT00295087?

This trial is currently completed. The enrollment target is 13 participants. The study started on 2005-11. Estimated completion is 2009-10.

What conditions does trial NCT00295087 study?

This clinical trial studies the following conditions: Premature Ovarian Failure.

Who is sponsoring clinical trial NCT00295087?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00295087 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Premature Ovarian Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00295087, the US trial registry maintained by the National Library of Medicine. NCT00295087 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.